York Capital Management Global Advisors’s Pfizer PFE Stock Holding History

York Capital Management Global Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,347,650	Closed	-$133M	–	88
2015 Q4	$133M	Buy	+4,347,650	New	+$137M	1.98%	18
2014 Q3	–	Sell	-4,827,057	Closed	-$136M	–	99
2014 Q2	$136M	Sell	4,827,057 -1,040,341	-18%	-$29.7M	1.35%	25
2014 Q1	$179M	Buy	+5,867,398	New	+$175M	2.08%	13

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

York Capital Management Global Advisors's PFE Position: Q1 2016 in Review

York Capital Management Global Advisors sold out of Pfizer (PFE) in Q1 2016, closing a stake of 4,347,650 shares — an estimated $133M sold.

York Capital Management Global Advisors first reported a position in PFE in Q1 2014 and held it in 3 quarters. The position peaked at $179M in Q1 2014. 1,967 funds tracked by Wall St. Rank hold PFE as of Q1 2016.

York Capital Management Global Advisors reported no remaining Pfizer position as of Q1 2016 after selling out during the quarter.
York Capital Management Global Advisors sold 4,347,650 Pfizer shares in Q1 2016, an estimated $133M.
York Capital Management Global Advisors first reported a position in Pfizer in Q1 2014 and held it in 3 quarters.
York Capital Management Global Advisors's Pfizer position peaked at $179M in Q1 2014.
1,967 funds tracked by Wall St. Rank held Pfizer as of Q1 2016.

Based on York Capital Management Global Advisors's 13F filing for Q1 2016, filed 16 May 2016.